• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估四种新鉴定的红斑丹毒丝菌表面蛋白的保护效力。

Evaluation of the protective efficacy of four newly identified surface proteins of Erysipelothrix rhusiopathiae.

机构信息

Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing, China; Animal Infectious Disease Unit, National State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, China; College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.

Animal Infectious Disease Unit, National State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, China; College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China; Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture, Wuhan, China; Cooperative Innovation Center for Sustainable Pig Production, Wuhan, China.

出版信息

Vaccine. 2018 Dec 18;36(52):8079-8083. doi: 10.1016/j.vaccine.2018.10.071. Epub 2018 Nov 13.

DOI:10.1016/j.vaccine.2018.10.071
PMID:30446176
Abstract

Erysipelothrix rhusiopathiae is the causative agent of animal erysipelas and human erysipeloid. Bacterial surface proteins are promising vaccine candidates. We recently identified 3 E. rhusiopathiae surface proteins (GAPDH, HP0728, and HP1472) and characterized their roles as virulence factors. However, their efficacy as protective antigens is still unknown. The N-terminal region of a previously identified surface protein, CbpB (CbpB-N), is speculated to be a protective antigen, but this needs to be verified. The aim of this study was to evaluate the protective efficacy of GAPDH, HP0728, HP1472, and CbpB-N. Immunization with recombinant GAPDH provided complete protection in a mouse model, recombinant CbpB-N provided partial protection, while recombinant HP0728 and HP1472 provided no protection. Recombinant GAPDH also provided good protection in a pig model. GAPDH antiserum exhibited significant blood bactericidal activity against E. rhusiopathiae. In conclusion, GAPDH and CbpB-N were found to be protective antigens of E. rhusiopathiae, and GAPDH is a promising vaccine candidate.

摘要

红斑丹毒丝菌是动物丹毒和人类类丹毒的病原体。细菌表面蛋白是有前途的疫苗候选物。我们最近鉴定了 3 种红斑丹毒丝菌表面蛋白(GAPDH、HP0728 和 HP1472),并研究了它们作为毒力因子的作用。然而,它们作为保护性抗原的功效尚不清楚。之前鉴定的表面蛋白 CbpB(CbpB-N)的 N 端区域被推测为保护性抗原,但这需要验证。本研究旨在评估 GAPDH、HP0728、HP1472 和 CbpB-N 的保护效力。用重组 GAPDH 免疫可在小鼠模型中提供完全保护,重组 CbpB-N 提供部分保护,而重组 HP0728 和 HP1472 则没有提供保护。重组 GAPDH 在猪模型中也提供了良好的保护。GAPDH 抗血清对红斑丹毒丝菌表现出显著的血液杀菌活性。总之,发现 GAPDH 和 CbpB-N 是红斑丹毒丝菌的保护性抗原,GAPDH 是一种很有前途的疫苗候选物。

相似文献

1
Evaluation of the protective efficacy of four newly identified surface proteins of Erysipelothrix rhusiopathiae.评估四种新鉴定的红斑丹毒丝菌表面蛋白的保护效力。
Vaccine. 2018 Dec 18;36(52):8079-8083. doi: 10.1016/j.vaccine.2018.10.071. Epub 2018 Nov 13.
2
Characterization of pathogenic roles of two Erysipelothrix rhusiopathiae surface proteins.鉴定两种猪红斑丹毒丝菌表面蛋白的致病作用。
Microb Pathog. 2018 Jan;114:166-168. doi: 10.1016/j.micpath.2017.11.057. Epub 2017 Nov 28.
3
Characterization and identification of a novel candidate vaccine protein through systematic analysis of extracellular proteins of Erysipelothrix rhusiopathiae.通过系统分析猪丹毒丝菌细胞外蛋白鉴定一种新型候选疫苗蛋白
Infect Immun. 2013 Dec;81(12):4333-40. doi: 10.1128/IAI.00549-13. Epub 2013 Sep 9.
4
Characterization of protective antigen CbpB as an adhesin and a plasminogen-binding protein of Erysipelothrix rhusiopathiae.猪丹毒杆菌保护性抗原CbpB作为黏附素和纤溶酶原结合蛋白的特性分析
Res Vet Sci. 2019 Jun;124:352-356. doi: 10.1016/j.rvsc.2019.04.002. Epub 2019 Apr 8.
5
Immunization with truncated recombinant protein SpaC of Erysipelothrix rhusiopathiae strain 715 serovar 18 confers protective immunity against challenge with various serovars.用猪丹毒杆菌715血清型18菌株的截短重组蛋白SpaC进行免疫接种可赋予针对各种血清型攻击的保护性免疫力。
Clin Vaccine Immunol. 2010 Dec;17(12):1991-7. doi: 10.1128/CVI.00213-10. Epub 2010 Oct 6.
6
Genetic and antigenic diversity of the surface protective antigen proteins of Erysipelothrix rhusiopathiae.猪丹毒杆菌表面保护性抗原蛋白的遗传和抗原多样性。
Clin Vaccine Immunol. 2007 Jul;14(7):813-20. doi: 10.1128/CVI.00099-07. Epub 2007 May 2.
7
[Immunity of native SpaA and recombinant SpaA-N against Erysipelothrix rhusiopathiae infection in mice].[天然SpaA和重组SpaA-N对小鼠感染猪红斑丹毒丝菌的免疫作用]
Wei Sheng Wu Xue Bao. 2010 Mar;50(3):367-72.
8
Erysipelothrix rhusiopathiae YS-1 as a live vaccine vehicle for heterologous protein expression and intranasal immunization of pigs.猪红斑丹毒丝菌YS-1作为用于异源蛋白表达和猪鼻内免疫的活疫苗载体。
Infect Immun. 2002 Jan;70(1):226-32. doi: 10.1128/IAI.70.1.226-232.2002.
9
Truncated surface protective antigen (SpaA) of Erysipelothrix rhusiopathiae serotype 1a elicits protection against challenge with serotypes 1a and 2b in pigs.猪红斑丹毒丝菌1a血清型的截短表面保护性抗原(SpaA)可使猪对1a和2b血清型的攻击产生保护作用。
Infect Immun. 1999 Sep;67(9):4376-82. doi: 10.1128/IAI.67.9.4376-4382.1999.
10
Protective activity of the purified protein antigen of Erysipelothrix rhusiopathiae in pigs.猪丹毒杆菌纯化蛋白抗原在猪体内的保护活性。
Zentralbl Veterinarmed B. 1999 Feb;46(1):47-55. doi: 10.1046/j.1439-0450.1999.00201.x.

引用本文的文献

1
Phenotypic and Genotypic Characterization of a Highly Virulent Strain.高毒力菌株的表型和基因型特征分析
Transbound Emerg Dis. 2024 Jul 26;2024:5401707. doi: 10.1155/2024/5401707. eCollection 2024.
2
Targeting Life Cycle with Novel Parasite Ligands as Vaccine Antigens.以新型寄生虫配体作为疫苗抗原靶向生命周期
Vaccines (Basel). 2024 Apr 30;12(5):484. doi: 10.3390/vaccines12050484.
3
Pathology, microbiology, and genetic diversity associated with and novel spp. infections in southern sea otters ().与南海獭()中新的 spp. 感染相关的病理学、微生物学和遗传多样性。
Front Microbiol. 2024 Feb 1;14:1303235. doi: 10.3389/fmicb.2023.1303235. eCollection 2023.
4
Combinations but Not a Single PlpE Epitope Induces Host Protective Immunity against Pasteurella multocida.组合而非单一 PlpE 表位诱导宿主对多杀性巴氏杆菌产生保护性免疫。
Infect Immun. 2023 Mar 15;91(3):e0027222. doi: 10.1128/iai.00272-22. Epub 2023 Feb 23.
5
Screening immune adjuvants for an inactivated vaccine against .筛选针对……的灭活疫苗的免疫佐剂。 (原文中against后缺少具体内容)
Front Vet Sci. 2022 Jul 26;9:922867. doi: 10.3389/fvets.2022.922867. eCollection 2022.
6
The Swine Erysipelas Vaccine SER-ME Effectively Protects Pigs against Challenge with the M203/I257 SpaA-Type Variant.猪丹毒疫苗SER-ME能有效保护猪抵御M203/I257 SpaA型变异株的攻击。
Vet Sci. 2022 Jul 26;9(8):382. doi: 10.3390/vetsci9080382.
7
Characterization of Isolates from Diseased Pigs in 15 Chinese Provinces from 2012 to 2018.2012年至2018年中国15个省份病猪分离株的特征分析
Microorganisms. 2021 Dec 17;9(12):2615. doi: 10.3390/microorganisms9122615.
8
Serovars and SpaA Types of Erysipelothrix rhusiopathiae Isolated from Pigs in Japan from 2012 to 2019.2012年至2019年从日本猪中分离出的猪丹毒丝菌血清型和SpaA型
Curr Microbiol. 2021 Jan;78(1):55-66. doi: 10.1007/s00284-020-02254-2. Epub 2020 Nov 3.
9
Spp.: Past, Present, and Future Directions in Vaccine Research.《物种:疫苗研究的过去、现在与未来方向》
Front Vet Sci. 2020 Apr 15;7:174. doi: 10.3389/fvets.2020.00174. eCollection 2020.
10
Genomic and Immunogenic Protein Diversity of Isolated From Pigs in Great Britain: Implications for Vaccine Protection.从英国猪中分离出的[具体内容缺失]的基因组和免疫原性蛋白质多样性:对疫苗保护的影响。
Front Microbiol. 2020 Mar 13;11:418. doi: 10.3389/fmicb.2020.00418. eCollection 2020.